Synthetic Curcumin Analog UBS109 Inhibits the Growth of Head and Neck Squamous Cell Carcinoma Xenografts

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|14|4|380-393

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.14, Iss.4, 2014-05, pp. : 380-393

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacotherapy for squamous-cell carcinoma of the head and neck

By Papaspyrou Giorgos   Werner Jochen A   Dietz Andreas  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 3, 2011-02 ,pp. : 397-409

Informa Healthcare

Access to resources Recommend Favorite

Afatinib in the treatment of head and neck squamous cell carcinoma

By Ferrarotto Renata   Gold Kathryn A  

Expert Opinion on Investigational Drugs, Vol. 23, Iss. 1, 2014-01 ,pp. : 135-143

Informa Healthcare

Access to resources Recommend Favorite

Progress in Immunotherapy of Head and Neck Squamous Cell Carcinoma

By  

Current Molecular Pharmacology, Vol. 9, Iss. 3, 2016-08 ,pp. : 226-230

Bentham Science Publishers

Access to resources Recommend Favorite

Epidermal growth factor receptor – targeted molecular therapeutics for head and neck squamous cell carcinoma

By Egloff Ann Marie   Grandis Jennifer  

Expert Opinion on Therapeutic Targets, Vol. 10, Iss. 5, 2006-10 ,pp. : 639-647

Informa Healthcare

Access to resources Recommend Favorite

Cisplatin + capecitabine active in head, neck squamous cell carcinoma

By  

Inpharma, Vol. 1, Iss. 1475, 2005-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite